Zobrazeno 1 - 10
of 244
pro vyhledávání: '"W. J. Fokkens"'
Autor:
S. Peeters, C. Wang, E. M. Bijnens, D. M. A. Bullens, W. J. Fokkens, C. Bachert, P. W. Hellings, T. S. Nawrot, S. F. Seys
Publikováno v:
Environmental Health, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background The aetiology of chronic rhinosinusitis (CRS) is multifactorial with a complex interplay between environmental, microbial endogenous and genetic factors. The impact of outdoor air pollution on prevalence or severity of CRS remains
Externí odkaz:
https://doaj.org/article/7d65220db74d4f3ba488e61a5d34033d
Autor:
N. Claeys, M. T. Teeling, P. Legrand, M. Poppe, P. Verschueren, L. De Prins, L. Cools, L. Cypers, W. J. Fokkens, C. Hopkins, P. W. Hellings
Publikováno v:
Frontiers in Allergy, Vol 2 (2021)
Externí odkaz:
https://doaj.org/article/7ad210091efd4eae85ace6dde2457929
Autor:
N. Claeys, M. T. Teeling, P. Legrand, M. Poppe, P. Verschueren, L. De Prins, L. Cools, L. Cypers, W. J. Fokkens, C. Hopkins, P. W. Hellings
Publikováno v:
Frontiers in Allergy, Vol 2 (2021)
Background: European patients with chronic rhinosinusitis with nasal polyps (CRSwNP) have had only limited occasions to unite to have their voices heard, hence missing the opportunity to contribute to the improvement of CRSwNP care.Aims: To identify
Externí odkaz:
https://doaj.org/article/e61859399cac4f80a92d4d991328c269
Autor:
J. Bousquet, A. Bedbrook, W. Czarlewski, G. L. Onorato, S. Arnavielhe, D. Laune, E. Mathieu-Dupas, J. Fonseca, E. Costa, O. Lourenço, M. Morais-Almeida, A. Todo-Bom, M. Illario, E. Menditto, G. W. Canonica, L. Cecchi, R. Monti, L. Napoli, M. T. Ventura, G. De Feo, W. J. Fokkens, N. H. Chavannes, S. Reitsma, A. A. Cruz, J. da Silva, F. S. Serpa, D. Larenas-Linnemann, J. M. Fuentes Perez, Y. R. Huerta-Villalobos, D. Rivero-Yeverino, E. Rodriguez-Zagal, A. Valiulis, R. Dubakiene, R. Emuzyte, V. Kvedariene, I. Annesi-Maesano, H. Blain, P. Bonniaud, I. Bosse, Y. Dauvilliers, P. Devillier, J. F. Fontaine, J. L. Pépin, N. Pham-Thi, F. Portejoie, R. Picard, N. Roche, C. Rolland, P. Schmidt-Grendelmeier, P. Kuna, B. Samolinski, J. M. Anto, V. Cardona, J. Mullol, H. Pinnock, D. Ryan, A. Sheikh, S. Walker, S. Williams, S. Becker, L. Klimek, O. Pfaar, K. C. Bergmann, R. Mösges, T. Zuberbier, R. E. Roller-Wirnsberger, P. V. Tomazic, T. Haahtela, J. Salimäki, S. Toppila-Salmi, E. Valovirta, T. Vasankari, B. Gemicioğlu, A. Yorgancioglu, N. G. Papadopoulos, E. P. Prokopakis, I. G. Tsiligianni, S. Bosnic-Anticevich, R. O’Hehir, J. C. Ivancevich, H. Neffen, M. E. Zernotti, I. Kull, E. Melén, M. Wickman, C. Bachert, P. W. Hellings, G. Brusselle, S. Palkonen, C. Bindslev-Jensen, E. Eller, S. Waserman, L. P. Boulet, J. Bouchard, D. K. Chu, H. J. Schünemann, M. Sova, G. De Vries, M. van Eerd, I. Agache, I. J. Ansotegui, M. Bewick, T. Casale, M. Dykewick, M. Ebisawa, R. Murray, R. Naclerio, Y. Okamoto, D. V. Wallace, The MASK study group
Publikováno v:
Clinical and Translational Allergy, Vol 9, Iss 1, Pp 1-19 (2019)
Abstract Aims Mobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life c
Externí odkaz:
https://doaj.org/article/387d2bfd7cb34c438e5aa80cf56def7a
Autor:
A. Valiulis, J. Bousquet, A. Veryga, U. Suprun, D. Sergeenko, S. Cebotari, D. Borelli, S. Pietikainen, J. Banys, I. Agache, N. E. Billo, A. Bush, I. Chkhaidze, L. Dubey, W. J. Fokkens, J. Grigg, T. Haahtela, K. Julge, O. Katilov, N. Khaltaev, M. Odemyr, S. Palkonen, R. Savli, A. Utkus, V. Vilc, T. Alasevicius, A. Bedbrook, M. Bewick, J. Chorostowska-Wynimko, E. Danila, A. Hadjipanayis, R. Karseladze, V. Kvedariene, E. Lesinskas, L. Münter, B. Samolinski, S. Sargsyan, B. Sitkauskiene, D. Somekh, L. Vaideliene, P. W. Hellings
Publikováno v:
Clinical and Translational Allergy, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Background Over 1 billion people suffer from chronic respiratory diseases such as asthma, COPD, rhinitis and rhinosinusitis. They cause an enormous burden and are considered as major non-communicable diseases. Many patients are still uncontr
Externí odkaz:
https://doaj.org/article/7b2ea02867d847929ae2b96552c8c5ad
Autor:
J. Bousquet, S. Arnavielhe, A. Bedbrook, M. Bewick, D. Laune, E. Mathieu-Dupas, R. Murray, G. L. Onorato, J. L. Pépin, R. Picard, F. Portejoie, E. Costa, J. Fonseca, O. Lourenço, M. Morais-Almeida, A. Todo-Bom, A. A. Cruz, J. da Silva, F. S. Serpa, M. Illario, E. Menditto, L. Cecchi, R. Monti, L. Napoli, M. T. Ventura, G. De Feo, D. Larenas-Linnemann, M. Fuentes Perez, Y. R. Huerta Villabolos, D. Rivero-Yeverino, E. Rodriguez-Zagal, F. Amat, I. Annesi-Maesano, I. Bosse, P. Demoly, P. Devillier, J. F. Fontaine, J. Just, T. P. Kuna, B. Samolinski, A. Valiulis, R. Emuzyte, V. Kvedariene, D. Ryan, A. Sheikh, P. Schmidt-Grendelmeier, L. Klimek, O. Pfaar, K. C. Bergmann, R. Mösges, T. Zuberbier, R. E. Roller-Wirnsberger, P. Tomazic, W. J. Fokkens, N. H. Chavannes, S. Reitsma, J. M. Anto, V. Cardona, T. Dedeu, J. Mullol, T. Haahtela, J. Salimäki, S. Toppila-Salmi, E. Valovirta, B. Gemicioğlu, A. Yorgancioglu, N. Papadopoulos, E. P. Prokopakis, S. Bosnic-Anticevich, R. O’Hehir, J. C. Ivancevich, H. Neffen, E. Zernotti, I. Kull, E. Melen, M. Wickman, C. Bachert, P. Hellings, S. Palkonen, C. Bindslev-Jensen, E. Eller, S. Waserman, M. Sova, G. De Vries, M. van Eerd, I. Agache, T. Casale, M. Dykewickz, R. N. Naclerio, Y. Okamoto, D. V. Wallace, MASK study group
Publikováno v:
Clinical and Translational Allergy, Vol 8, Iss 1, Pp 1-21 (2018)
Abstract mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching th
Externí odkaz:
https://doaj.org/article/0a9a93c71ddf464189aa653c1d6ab3c9
Autor:
D. Samreth, S. Arnavielhe, F. Ingenrieth, A. Bedbrook, G. L. Onorato, R. Murray, R. Almeida, M. A. Mizani, J. Fonseca, E. Costa, J. Malva, M. Morais-Almeida, A. M. Pereira, A. Todo-Bom, E. Menditto, C. Stellato, M. T. Ventura, D. Larenas-Linnemann, J-M. Fuentes-Pérez, Y. R. Huerta-Villalobos, A. A. Cruz, R. Stelmach, J. da Silva, R. Emuzyte, V. Kvedariene, A. Valiulis, I. Annesi-Maesano, I. Bosse, P. Demoly, P. Devillier, J. F. Fontaine, P. Kuna, B. Samolinski, L. Klimek, R. Mösges, O. Pfaar, S. Shamai, M. Bewick, D. Ryan, A. Sheikh, J. M. Anto, V. Cardona, J. Mullol, A. Valero, N. H. Chavannes, W. J. Fokkens, S. Reitsma, R. E. Roller-Wirnsberger, P. V. Tomazic, T. Haahtela, S. Toppila-Salmi, E. Valovirta, M. Makris, N. G. Papadopoulos, E. P. Prokopakis, F. Psarros, B. Gemicioğlu, A. Yorgancioglu, C. Bindslev-Jensen, E. Eller, I. Kull, M. Wickman, C. Bachert, P. W. Hellings, B. Pugin, S. Bosnic-Anticevich, R. E. O’Hehir, V. Kolek, M. Sova, K. Wehner, G. De Vries, M. van Eerd, D. Laune, J. Wittmann, J. Bousquet, P. Poncelet, the MASK study group
Publikováno v:
World Allergy Organization Journal, Vol 11, Iss 1, Pp 1-13 (2018)
Abstract Background Collecting data on the localization of users is a key issue for the MASK (Mobile Airways Sentinel networK: the Allergy Diary) App. Data anonymization is a method of sanitization for privacy. The European Commission’s Article 29
Externí odkaz:
https://doaj.org/article/ff375fdcaf7348e18be2dde887f100e6
Autor:
J. Bousquet, G. L. Onorato, C. Bachert, M. Barbolini, A. Bedbrook, L. Bjermer, J. Correia de Sousa, N. H. Chavannes, A. A. Cruz, E. De Manuel Keenoy, P. Devillier, J. Fonseca, S. Hun, T. Kostka, P. W. Hellings, M. Illario, J. C. Ivancevich, D. Larenas-Linnemann, J. Millot-Keurinck, D. Ryan, B. Samolinski, A. Sheikh, A. Yorgancioglu, I. Agache, S. Arnavielhe, M. Bewick, I. Annesi-Maesano, J. M. Anto, K. C. Bergmann, C. Bindslev-Jensen, S. Bosnic-Anticevich, J. Bouchard, D. P. Caimmi, P. Camargos, G. W. Canonica, V. Cardona, A. M. Carriazo, C. Cingi, E. Colgan, A. Custovic, R. Dahl, P. Demoly, G. De Vries, W. J. Fokkens, J. F. Fontaine, B. Gemicioğlu, N. Guldemond, Z. Gutter, T. Haahtela, B. Hellqvist-Dahl, E. Jares, G. Joos, J. Just, N. Khaltaev, T. Keil, L. Klimek, M. L. Kowalski, I. Kull, P. Kuna, V. Kvedariene, D. Laune, R. Louis, A. Magnan, J. Malva, E. Mathieu-Dupas, E. Melén, E. Menditto, M. Morais-Almeida, R. Mösges, J. Mullol, R. Murray, H. Neffen, R. O’Hehir, S. Palkonen, N. G. Papadopoulos, G. Passalacqua, J. L. Pépin, F. Portejoie, D. Price, B. Pugin, F. Raciborski, F. E. R. Simons, M. Sova, O. Spranger, C. Stellato, A. Todo Bom, P. V. Tomazic, M. Triggiani, A. Valero, E. Valovirta, O. VandenPlas, A. Valiulis, M. van Eerd, M. T. Ventura, M. Wickman, I. Young, T. Zuberbier, A. Zurkuhlen, A. Senn
Publikováno v:
Clinical and Translational Allergy, Vol 7, Iss 1, Pp 1-16 (2017)
Abstract A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice
Externí odkaz:
https://doaj.org/article/72e8b04b2d2f486db75e1281e3812453
Autor:
C. Cingi, P. Gevaert, R. Mösges, C. Rondon, V. Hox, M. Rudenko, N. B. Muluk, G. Scadding, F. Manole, C. Hupin, W. J. Fokkens, C. Akdis, C. Bachert, P. Demoly, J. Mullol, A. Muraro, N. Papadopoulos, R. Pawankar, P. Rombaux, E. Toskala, L. Kalogjera, E. Prokopakis, P. W. Hellings, J. Bousquet
Publikováno v:
Clinical and Translational Allergy, Vol 7, Iss 1, Pp 1-12 (2017)
Abstract This report has been prepared by the European Academy of Allergy and Clinical Immunology Task Force on Allergic Rhinitis (AR) comorbidities. The aim of this multidisciplinary European consensus document is to highlight the role of multimorbi
Externí odkaz:
https://doaj.org/article/52752fb668194db4bfbcf52953c39078
Autor:
W J Fokkens, A-S Viskens, V Backer, D Conti, E De Corso, P Gevaert, G K Scadding, M Wagemann, M Bernal-Sprekelsen, A Chaker, E Heffler, J K Han, E Van Staeyen, C Hopkins, J Mullol, A Peters, S Reitsma, B A Senior, P W Hellings
Publikováno v:
Rhinology Journal.
Severe chronic rhinosinusitis with nasal polyps (CRSwNP) is a debilitating disease with a significant impact on the quality of life (QoL). It is typically characterized by a type 2 inflammatory reaction and by comorbidities such as asthma, allergies